[S-27] Current topics in Guillain-Barré syndrome - from pathophysiology to clinical features

[S-27-4] Nodopathy: The third electrophysiologic category in Guillain-Barré syndrome

Satoshi Kuwabara (Department of Neurology, Graduate School of Medicine, Chiba University, Japan)

This symposium is designed to introduce novel international studies of clinical and basic research from leading laboratories as well as to discuss current topics in the field of Guillain-Barré syndrome (GBS). The International GBS Outcome Study (IGOS) which has been just accomplished is a worldwide prospective, collaborative study of GBS, results of which will be global standards and provide evidence about a new clinical guideline of GBS. In addition, recently-reported new observations of antibody-mediated pathophysiology in GBS are expected to improve diagnostic approach, change the concept of electrophysiological categories, and develop promising immunotherapies and treatment strategy. This symposium will stimulate neurologists to absorb such novel knowledge and to put it to a practical use without regard to their specialty.

Professor Kuwabara is the Chair of Neurology at Chiba University. He is a clinical neurologist, Deputy Editor of the Journal of Neurology, Neurosurgery and Psychiatry, and Chief Reviewer of Cochrane Database Systematic Review; “Treatment for POEMS syndrome”.
He graduated from Chiba university in 1984 (MD), and completed his neurology residency at Japanese city hospitals (1986-1993) and studied clinical neurophysiology under Prof. David Burke at University of new South Wales (1999-2000). Dr. Kuwabara has extensively studied clinical neurophysiology and neuroimmunology through the interpretation and treatment of neuromuscular disease such as Guillain-Barre syndrome, CIDP, and POEMS syndrome. He has published 450 peer reviewed articles.